Skip to Content
Center for International Blood and Marrow Transplant Research

IB18-03

Main Content

The effect of human leukocyte antigen class I heterozygosity and human leukocyte antigen supertypes on outcomes following allogeneic hematopoietic cell transplant for myeloid and lymphoid malignancies.

Study #: IB18-03

Study Status: Published

Presentation(s)

2019, Tandem (Poster)

Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes.

Citation

Camacho-Bydume C, Wang T, Sees JA, Fernandez-Viña M, Abid MB, Askar M, Beitinjaneh A, Brown V, Castillo P, Chhabra S, Gadalla SM, Hsu JM, Kamoun M, Lazaryan A, Nishihori T, Page K, Schetelig J, Fleischhauer K, Marsh SGE, Paczesny S, Spellman SR, Lee SJ, Hsu KC.

Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2021, Feb 01: 27(2): 27(2):142.e1-142.e11. doi: 10.1016/j.bbmt.2020.10.010. Epub 2020, Oct 11. PMCID:PMC8015676.

PubMed

PMID: 33053450

Abstract